TORONTO, July 18, 2019 /PRNewswire/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced its interim financial results for the second quarter ended May 31, 2019. All financial figures are in Canadian dollars unless otherwise indicated.

MINNEAPOLIS, July 18, 2019 /PRNewswire/ -- While a hot summer day might have you reaching for a fruit juice, the Minnesota Dental Association encourages parents and caregivers to be aware of sugar content in these thirst-quenching beverages and limit the amount given to children. Tooth decay is the most common chronic childhood disease in

LINCOLN, Neb., July 18, 2019 /PRNewswire/ -- Kootenai Health, a regional medical center in northern Idaho, has partnered with Vosaic

COLUMBUS, Ga., July 18, 2019 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release second quarter financial results after the market closes on July 25, 2019.In conjunction with the earnings release, Aflac Incorporated will webcast a conference call scheduled for 9:00 a.m. (E

SAN FRANCISCO, July 18, 2019 /PRNewswire/ -- Today, Vitagene, the leading platform for personalized health products, announced its intention to acquire In-Video Impressions, an audience targeting, digital advertising, and customer acquisition company. In-Video's CEO, Nikhil Arun, will join Vitagene as the Head of Growth. With this acqu

BALTIMORE, Md., July 18, 2019 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, will announce financial results for the second quarter ended June 30, 2019 on Thursday, August 1, 2019, after market close. The Company will

DUBLIN, July 18, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p

CAMBRIDGE, Mass., July 18, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the European Medicines Agency (EMA) has validated the company's Marketing Authorization Application (MAA) for avapritinib for the treatment of

WESTBROOK, Maine, July 18, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today the election of Sam Samad, the Senior Vice President and Chief Financial Officer of Illumina, Inc., as a member of the

WILLOWBROOK, Ill., July 18, 2019 /PRNewswire/ -- Pharmazz, Inc., today announced that it has received permission to initiate a prospective, multicentric, randomized, double-blind, parallel, phase III clinical study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke in India. PMZ-1620 (IR